Podcasts about stat news

For years, scientists worried that medical progress was slowing down. Drug development became more expensive than ever with more complex clinical trials, and even then, many new treatments offered only modest gains. But over the past month, a series of breakthroughs has raised hopes that medicine may be entering a new era. Researchers unveiled a massively promising new therapy for pancreatic cancer, a gene-editing treatment that could dramatically reduce the risk of heart disease, and an experimental obesity drug that not only produces unprecedented weight loss but also improves a huge range of related conditions. Cancer and heart disease are America's two biggest killers, but if these treatments fulfill their promise, they could transform public health and extend millions of lives. Today's guest is Matthew Herper, senior writer at STAT News. We discuss this remarkable month in medicine, why so many advances are arriving at once, and what they could mean for the future of human health. Subscribe to our YouTube channel here:https://www.youtube.com/@PlainEnglishwithDerekThompson If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek ThompsonGuest: Matthew HerperProducer: Devon BaroldiAdditional Production Support: Ben Glicksman All Matches Streaming Live. Watch 3 Days Free. Offers are subject to change. See fox.com for complete terms and conditions. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hay muchísimas formas de hacer investigación, pero la mayoría solo conocemos una: la del laboratorio académico clásico. Es el agua en la que nadamos sin darnos cuenta de que es agua.Una sola pregunta desmonta el sistema entero: ¿cuándo y cómo entran los datos en tu proyecto? Esa decisión condiciona quién manda, cuándo termina el proyecto y qué cuenta como éxito.En este episodio recorro una línea con 10 modelos ordenados por cuándo entra el dato, desde el dato congelado hasta el dato que pide un algoritmo.Laboratorio académico clásico: el dato entra una vez y se congela.Bell Labs: "correa larga, valla estrecha". Dato continuo dentro de una empresa.Institutos independientes (Arc Institute, etc.): financiación a varios años, poca presión por publicar.Ciencia ciudadana: el público recoge datos de forma distribuida y constante.Big Science (CERN, Hubble): datos en chorro permanente, papers con miles de autores.FRO: 15 a 30 personas, 5 años, dinero filantrópico, sin obligación de publicar.DARPA: un Program Manager con poder real marca hitos. Así nació Internet.DeSci: financiación y propiedad intelectual en blockchain entre holders de tokens.Self-Driving Lab: bucle DMTA. El dato entra a demanda; cada vuelta decide el siguiente experimento.Radial: rediseñar el proceso científico como ingeniería, en ciclos, a nivel de sistema.El laboratorio autónomo es el extremo más radical: no tiene final, sigue optimizando mientras lo dejes encendido. Eso es justo lo que el sistema científico actual no sabe gestionar.Lo más profundo: ¿quién decide qué dato pedir? En el modelo clásico, el investigador. En Big Science, un comité. En DARPA, el Program Manager. En DeSci, una comunidad. En el laboratorio autónomo, un algoritmo. No estamos automatizando el pipeteo: estamos delegando la autoría intelectual del siguiente paso.La razón por la que casi ninguno nace en la academia es sencilla: la academia solo sabe puntuar papers. No es un problema de calidad, es un problema de contabilidad del mérito.¿Tu problema pide un bucle? Porque si lo estás forzando dentro del molde del paper, estás remando contra tu propio problema.Comunidad de investigadores: https://horacio-ps.com/comunidadNewsletter: https://horacio-ps.com/newsletterSi el episodio te ha resultado útil, dale like, suscríbete o compártelo en Spotify, Apple Podcasts, iVoox o YouTube.Enlaces y referenciasTony Blair Institute, "A New Model for Science": https://institute.global/insights/tech-and-digitalisation/new-model-scienceFuture Blind (Max Olson), "The new wave of science and research models": https://futureblind.com/p/the-new-wave-of-science-and-research-modelsConstruction Physics (Brian Potter), "The Influence of Bell Labs": https://www.construction-physics.com/p/the-influence-of-bell-labsArc Institute, "The Arc Model": https://arcinstitute.org/modelFranzoni y Sauermann (2014), Research Policy 43(1), pp. 1-20: https://ideas.repec.org/r/eee/respol/v43y2014i1p1-20.htmlBritannica, "Big Science": https://www.britannica.com/science/Big-Science-scienceFederation of American Scientists, "FROs: A New Model": https://fas.org/publication/focused-research-organizations-a-new-model-for-scientific-research/Ethereum.org, "Decentralized science (DeSci)": https://ethereum.org/desci/Tom et al. (2024), Chemical Reviews 124(16), pp. 9633-9732: https://pubs.acs.org/doi/abs/10.1021/acs.chemrev.4c00055Autonomous Chemical Experiments, Acc. Chem. Res. (2022): https://pmc.ncbi.nlm.nih.gov/articles/PMC9454899/Astera, "Announcing Radial": https://astera.org/announcing-radial/Seemay Chou, "Scientific Publishing: Enough is Enough": https://astera.org/scientific-publishing-enough-is-enough/STAT News sobre Radial: https://www.statnews.com/2026/03/11/radial-ai-science-astera-nonprofit/Nature, "Inside the self-driving lab revolution": https://www.nature.com/articles/d41586-026-00974-2Nature, "Will self-driving robot labs replace biologists?": https://www.nature.com/articles/d41586-026-00453-8

Jonathan Howard and Wendy Orent call this week their "Red Wedding": within days, FDA Commissioner Marty Makary resigned, Vinay Prasad was pushed out of CBER, Tracy Beth Hoeg was fired, and Senator Bill Cassidy lost his Louisiana primary. The hosts argue this is not a tragedy but a long-foretold collapse — a group of physicians who built careers as COVID-era contrarian podcasters discovering that running a regulatory agency is fundamentally different from posting about one. Howard works through the wreckage: Makary's reported approval of flavored nicotine products days before his ouster, the FDA's treatment of the rare disease community, the leaked memo claiming pediatric COVID vaccine deaths that career staff refused to sign off on, and the broader pattern of "regulatory whiplash" that drove the agency into dysfunction. The episode then turns to who is still standing — Jay Bhattacharya at NIH, Robert F. Kennedy Jr. at HHS — and what Kennedy is reportedly doing to vaccines from behind the scenes via Martin Kulldorff's review effort. Throughout, the hosts return to a single thesis: the skills that made Makary, Prasad, Hoeg, and Cassidy famous during COVID — opinion, tweeting, posturing — do not translate into running institutions, and the medical commentators who vouched for them (John Mandrola, Adam Cifu) have lost any remaining credibility. Key Topics Discussed Bill Cassidy's primary loss and the cost of the Kennedy confirmation vote Cassidy's earlier vote to convict Trump after January 6 followed by his decisive vote advancing RFK Jr. as HHS Secretary. Howard and Orent's view that Cassidy's promise to "keep Kennedy in line" was hollow from the start. What Cassidy's defeat signals about Trump's grip on the Republican base in Louisiana — and the hosts' read that his lame-duck status may give him cover to block the next round of HHS nominees. Marty Makary's resignation and the "worst FDA Commissioner in 25 years" framing The Stat News piece characterizing Makary's tenure, and the reporting that flavored nicotine was the precipitating issue with Trump's tobacco-industry donors. Howard's counterpoint: Makary reportedly approved a batch of electronic nicotine delivery systems (ENDS) on May 5, 2026 — the weekend before he resigned — undercutting the "principled stand" narrative. The pattern of selfie videos, public-facing performance, and what former FDA staff describe as hostile management of career scientists. Makary's pre-FDA record: the "medical error is the third leading cause of death" claim, Omicron as "nature's vaccine," "Omicold," herd immunity calls in May 2021, and the Nazi-bioweapon Lyme disease theory amplification. Vinay Prasad, regulatory whiplash, and the rare disease community How Prasad's stated preference for randomized controlled trials translated into rejection of rare disease therapies — and the disconnect between calling for RCTs on Twitter and the practical impossibility of running them for small patient populations. Right-to-try advocates, the libertarian wing of MAHA (Senator Ron Johnson), and why they turned on Prasad. Howard's point: Pfizer's halted COVID vaccine RCT in 50–65-year-olds is the case study — the trials Prasad demanded couldn't actually be enrolled. Tracy Beth Hoeg, the leaked pediatric deaths memo, and the Maryanne Demasi interview Hoeg's insistence she was fired, not resigned, and her interview with Brownstone Institute–adjacent journalist Maryanne Demasi. Her claim that the chaos at the FDA was "created by the media" rather than real. The memo alleging 10 pediatric deaths from the COVID vaccine that career FDA staff would not sign off on — and Howard's contrast with the J&J/thrombosis response, where nine deaths produced immediate, transparent action. Hoeg's role in the Denmark-style vaccine schedule rollback memo alongside Makary. The Makary–Prasad ZDoggMD clip on FDA "vindictiveness" — and the irony Audio pulled from a pre-appointment Prasad/Makary appearance describing the FDA as "erratic," "capricious," and politically pressured. Howard's read: every criticism they leveled at the Biden-era FDA describes their own tenure — political pressure from Trump, demoted career staff, inconsistent standards. The Peter Marks / Marion Gruber / Phil Krause booster episode reframed in light of what followed. John Mandrola, Adam Cifu, and the cost of vouching Mandrola's "Can We Give the New FDA's Leadership a Chance?" piece a year earlier — and the line about Prasad and Makary inducing companies to run proper RCTs, set against Pfizer's halted trial. Howard's account of an email exchange with Cifu following Cifu's visit to NYU — Howard's offer of a serious content-level conversation, and Cifu's decline. The broader "medical conservatives" project and what the hosts argue has happened to its credibility. Jay Bhattacharya, NIH, and the resignation letter from departing staff The letter from a senior NIH scientist on Bhattacharya's leadership — political termination of grants, deals institutions are making to recover funding, and Bhattacharya's silence. Howard and Orent's read on Bhattacharya's visible deterioration and his retreat into Great Barrington nostalgia. Kennedy's behind-the-scenes vaccine review and Martin Kulldorff The New York Times reporting (Christina Jewett and Sheryl Gay Stolberg) on Kennedy's vaccine inquiry being led by Kulldorff. Howard's pushback on the framing of Kulldorff as merely "a critic of restrictions and mandates" — and the 2020 record of his herd-immunity-through-infection advocacy, including his Stockholm "almost at herd immunity" claim in April 2020. The hosts' concern that the COVID amnesia project lets pandemic-era pro-infection figures re-enter regulatory power with their record sanitized. Casey Means, Surgeon General nomination withdrawal, and MAHA fracturing The withdrawn Surgeon General nomination and what it signals. The Robert Malone vs. Makary public falling-out over the unreleased pediatric deaths data. Why the MAHA coalition — held together by shared COVID grievance — is coming apart now that COVID has receded from headlines. Notable Moments On Cassidy: "He betrayed his oath as a physician, he betrayed the American people, and he's going down into the ignominious dust." — Wendy Orent On the Makary–Prasad–Hoeg trio: "The same skill sets that catapulted these guys to power — essentially being excellent podcasters — do not translate into leading a government agency of tens of thousands of employees that regulates 20 percent of the US economy." — Jonathan Howard On the legacy: "These guys are now cautionary tales for medical students. I would love to teach a course called 'Be the Opposite of Bill Cassidy, Marty Makary, Vinay Prasad, and Tracy Beth Hoeg.'" — Jonathan Howard On Bhattacharya: "His soul has been totally corrupted by the people who he teamed up with. You also see it in his face. He's not the same person that took the position." — Jonathan Howard References Mentioned in the Episode Stat News — "Why Marty Makary Was the Worst FDA Commissioner in 25 Years" Vinay Prasad's 2016 Stat News rebuttal of Makary's "medical error" claim David Gorski (Science-Based Medicine, 2016) — rebuttal of the medical-error-as-third-leading-cause-of-death claim Jonathan Howard, Science-Based Medicine — recent piece compiling Makary's COVID-era statements New York Times — Christina Jewett and Sheryl Gay Stolberg on Kennedy's vaccine inquiry Washington Post — "Ouster of RFK's Allies Tests MAHA-Trump Alliance" Ben Mazer, The Atlantic — on whether Makary and Prasad enacted lasting change Francis Lee — In COVID's Wake Alfred Crosby — America's Forgotten Pandemic Maryanne Demasi interview with Tracy Beth Hoeg MedPage Today — Makary and Prasad, "The Importance of Humility in Medicine" People Referenced Marty Makary — outgoing FDA Commissioner Vinay Prasad — former CBER Director Tracy Beth Hoeg — fired FDA official Senator Bill Cassidy (R-LA) — lost primary Robert F. Kennedy Jr. — HHS Secretary Jay Bhattacharya — NIH Director Martin Kulldorff — leading Kennedy's vaccine review Peter Marks — former CBER Director, Operation Warp Speed Bob Kadlec — Operation Warp Speed David Kessler — former FDA Commissioner (referenced) Marion Gruber and Phil Krause — former FDA vaccine reviewers John Mandrola and Adam Cifu — "medical conservative" commentators Robert Malone — anti-vaccine activist Casey Means — withdrawn Surgeon General nominee Senator Ron Johnson (R-WI) Representative Jake Auchincloss — opened FDA whistleblower line Art Caplan — bioethicist (retirement) Erica Schwartz — CDC Director nominee, unconfirmed  

US equity markets rallied on Friday (22 May) ahead of the holiday long weekend albeit finished off their best levels of the session – Dow rose +294-points or +0.58% to log a fresh record closing high of 50,579.70 for a second consecutive session after scaling a record intra-day peak (50,830.24). Merck & Co rallied +5.64% to be the leading performer in the 30-stock index following a report by STAT News that its lung cancer treatment being developed with China-based Kelun-Biotech, sacituzumab tirumotecan, cut tumour progression risk by 65% and also yielded a survival benefit in a Phase 3 study conducted in China. The drug was used on patients in combination with Merck's Keytruda, the company's immunotherapy used to treat a wide variety of cancers. However, Nvidia Corp (down -1.9%) declined for a second session running following the release of its first quarter result after the close last Wednesday (20 May).

US equity markets rallied on Friday (22 May) ahead of the holiday long weekend albeit finished off their best levels of the session – Dow rose +294-points or +0.58% to log a fresh record closing high of 50,579.70 for a second consecutive session after scaling a record intra-day peak (50,830.24). Merck & Co rallied +5.64% to be the leading performer in the 30-stock index following a report by STAT News that its lung cancer treatment being developed with China-based Kelun-Biotech, sacituzumab tirumotecan, cut tumour progression risk by 65% and also yielded a survival benefit in a Phase 3 study conducted in China. The drug was used on patients in combination with Merck's Keytruda, the company's immunotherapy used to treat a wide variety of cancers. However, Nvidia Corp (down -1.9%) declined for a second session running following the release of its first quarter result after the close last Wednesday (20 May).

On Sunday, the World Health Organization declared the ebola outbreak in Congo and Uganda "a public health emergency of international concern". We speak with infectious disease correspondent, Helen Branswell with Stat News, and Dr. Joanne Liu, a physician and professor at McGIll University's School of Population and Global Health, and former International President Médecins Sans Frontières, who led the international response to the West African Ebola epidemic from 2014-2016.

Health and Human Services Secretary Robert F. Kennedy, Jr. has testified before Congress several times over the past month. Chelsea Cirruzzo, Washington Correspondent for STAT News, offers analysis as to why he seemed to move away from some of the more radical MAHA messaging he has promoted in the past. Photo: Secretary Robert F. Kennedy Jr. delivers remarks at a White House event announcing the Make America Healthy Again Commission on May 22, 2025. (Credit: Joyce N. Boghosian/White House via Wikimedia Commons)

About 20,000 seafarers are stranded in the Persian Gulf as the U.S. and Iran remain in a standoff over the control of the Strait of Hormuz. John Canias of the International Transport Workers' Federation explains the conditions these workers are facing.And, a revolutionary new drug could prolong and improve the quality of life for those suffering from pancreatic cancer. STAT News reporter Angus Chen shares more about the breakthrough.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

The industry-wide debate about how pervasive and deep-seeded vaccine skepticism is in America got an unexpected jolt last week. A poll conducted by Public First on behalf of Politico found that 46% of adults believe the facts on vaccines are still up for debate and it is damaging to enforce their uptake. Yet not everyone has bought into Politico's findings, with some expressing skepticism about the skepticism. In a pointed op-ed published in STAT News a few days later, physician Dan Higgins argued that Politico's poll was badly worded and made vaccine skepticism look more common than it is – which he said is dangerous.  More than six years after the start of the COVID-19 pandemic and the latest, most galvanizing iteration of the anti-vaccine movement, the importance of marketing and communications around vaccines cannot be understated.  For this week's feature interview, pharma editor Lecia Bushak sits down with Tim Lee, chief commercial officer at Invivyd, to discuss the shift among vaccine manufacturers post-COVID, why clear, science-based messaging can change the narrative and what role monoclonal antibodies can play as an alternative to traditional vaccines. After the feature interview, you'll also get to hear from us following our win at the Neal Awards as well as a few conversations from our recent Transform conference.  Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What if one of the biggest health threats on Earth… is something you can't see, taste, or even fully measure yet? In this urgent solo episode, Darin breaks down the rapidly escalating crisis of microplastics and nanoplastics infiltrating our bodies, water systems, and environment. What was once dismissed is now being acknowledged at the highest levels, with government agencies scrambling to understand and contain the damage. From plastics crossing the blood-brain barrier to disrupting hormones and carrying toxic chemicals deep into human tissue, this episode exposes the hidden cost of modern convenience, and more importantly, gives you practical, immediate actions you can take to protect yourself and your family. What You'll Learn Why microplastics are now considered a global health emergency How plastics accumulate in your body and environment The shocking truth about nanoplastics crossing the blood-brain barrier How plastics act as endocrine disruptors affecting hormones The connection between plastics and inflammation, fertility, and disease Why tap water and bottled water are both major exposure sources The role of PFAS ("forever chemicals") in long-term health damage How to filter and detox microplastics from your body Emerging science on breaking down plastics using bacteria and plants Simple, actionable steps to dramatically reduce your exposure Chapters 00:00:00 – Welcome to SuperLife 00:02:12 – Opening: committing to a clean, conscious life 00:02:27 – Fatal conveniences and why awareness matters 00:02:46 – Government officially flags microplastics as a crisis 00:03:04 – $100M+ initiatives to understand plastic contamination 00:03:38 – Microplastics in drinking water and daily exposure 00:04:20 – Plastics found in babies and human brains 00:04:45 – Why we still don't understand the full damage 00:05:08 – Nanoplastics crossing the blood-brain barrier 00:05:33 – Plastics as endocrine disruptors 00:06:02 – Hormonal imbalance, inflammation, and toxicity 00:06:30 – PFAS and the "forever chemical" crisis 00:06:59 – The #1 rule: stop using single-use plastic bottles 00:07:27 – Hidden dangers of "BPA-free" plastics 00:07:58 – Why you can no longer trust tap water 00:08:30 – The importance of high-quality water filtration 00:09:11 – Reverse osmosis systems and best practices 00:10:17 – Detox strategies: sweating and sauna use 00:10:59 – Fiber and plant-based diets binding toxins 00:11:24 – Medicinal mushrooms and beta glucans 00:11:52 – Microbes that break down plastic polymers 00:12:32 – Plant-based flocculants (okra, fenugreek) removing plastics 00:13:20 – Bio-sponges and advanced filtration innovations 00:13:46 – Magnetic separation technology 00:14:27 – Microplastics from clothing and laundry systems 00:15:16 – AI-assisted filtration and regulatory changes 00:15:55 – Light-activated breakdown of plastics 00:16:03 – Boiling water to remove up to 90% of microplastics 00:16:33 – Practical emergency water filtration methods 00:16:59 – Creating a low-toxicity lifestyle at home 00:17:20 – Final message: take control and protect your health 00:17:32 – Outro     Thank You to Our Sponsors Tru Niagen – Boost NAD+ levels for cellular health and longevity. Get 20% off with code DARIN20 at truniagen.com. Shakeology – Shakeology-All in One Nutrition: Get 15% off with code SUPERLIFE at Shakeology.com.     Join the SuperLife Patreon: This is where Darin now shares the deeper work: - weekly voice notes - ingredient trackers - wellness challenges - extended conversations - community accountability - sovereignty practices Join now for only $7.49/month at https://patreon.com/darinolien     Connect with Darin Olien: Website: darinolien.com Instagram: @darinolien Book: Fatal Conveniences Platform & Products: superlife.com New Show: Roadmap to Happiness     Key Takeaway: "We are living in a world where convenience has quietly introduced toxins into nearly every aspect of our lives, but you are not powerless. The moment you become aware, you can take action. And the small choices you make every day: what you drink from, how you filter your water, what you put into your body, can dramatically shift your long-term health and your family's future."     Bibliography/Sources: The News Hook — EPA CCL6 & STOMP Initiative Chemical & Engineering News. (2026, April 3). US government targets microplastics for research and potential drinking-water regulation. American Chemical Society. https://cen.acs.org Environmental Protection Agency. (2026, April 2). EPA takes bold action to ensure drinking water is safe from microplastics, pharmaceuticals, and potential hidden contaminants [Press release]. https://www.epa.gov/newsreleases Environmental Protection Agency & Department of Health and Human Services. (2026, April 2). EPA, HHS announce historic actions to protect Americans from microplastics and safeguard drinking water [Press release]. https://www.epa.gov/newsreleases Inside Climate News. (2026, April 3). EPA flags microplastics as 'priority' water contaminants, but the move doesn't guarantee regulation. https://insideclimatenews.org National Public Radio. (2026, April 2). EPA flags microplastics, pharmaceuticals as contaminants in drinking water. https://www.npr.org STAT News. (2026, April 2). EPA to put microplastics on study list of contaminants in drinking water. https://www.statnews.com The New Lede. (2026, April 2). EPA flags microplastics as 'priority' contaminants in drinking water. https://thenewlede.org U.S. Government. (2026). Public comment docket: EPA-HQ-OW-2022-0946. https://www.regulations.gov The Science — Brain Invasion & Cellular Damage ACS Environment & Health. (2025). Neurotoxicity of micro- and nanoplastics: A comprehensive review of CNS impacts. American Chemical Society. https://pubs.acs.org Journal of Nanobiotechnology. (2025). Maternal nanoplastic exposure led to impaired neuronal development in the fetal cortex. Springer Nature. PubMed Central. (2023). Micro-/nanoplastics breach the blood-brain barrier: Biomolecular corona's role revealed. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov PubMed Central. (2024). A review on micro- and nanoplastics in humans: Translocation of barriers and potential health effects. National Institutes of Health. https://pubmed.ncbi.nlm.nih.gov PubMed Central. (2025). Overall effects of microplastics on brain. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov ScienceDirect. (2025). Mechanisms of micro- and nanoplastics on blood-brain barrier crossing and neurotoxicity. Elsevier. https://www.sciencedirect.com The Science — Endocrine Disruption & Gut Health eClinicalMedicine. (2026). Phthalates attributed to nearly 2 million preterm births globally. The Lancet. Frontiers in Cellular and Infection Microbiology. (2024). Microplastics, human health, and the gut microbiome. Frontiers. https://www.frontiersin.org Frontiers in Endocrinology. (2023). A review of the endocrine disrupting effects of micro and nano plastic in mammals. Frontiers. International Journal of Molecular Sciences. (2025). Micro- and nanoplastics as disruptors of the endocrine system. MDPI. https://www.mdpi.com PubMed Central. (2025). Microplastics, endocrine disruptors, and oxidative stress. National Institutes of Health. Solutions — Filtration & Global Removal Technologies ACS Applied and Environmental Microbiology. (2024). Eco-microbiology: Discovering biochemical enhancers of PET biodegradation by Piscinibacter sakaiensis. American Chemical Society. ACS Omega. (2025). Thermostability and activity improvements of PETase from Ideonella sakaiensis. American Chemical Society. Environmental Science & Technology Letters. (2024). Drinking boiled tap water reduces human intake of nanoplastics and microplastics. American Chemical Society. https://doi.org/10.1021/acs.estlett.4c00081 Srinivasan, R., et al. (2025). Fenugreek and okra polymers as treatment agents for the removal of microplastics from water sources. ACS Omega. https://doi.org/10.1021/acsomega.4c07476 Yoshida, S., et al. (2016). A bacterium that degrades and assimilates poly(ethylene terephthalate). Science.  

In this week's conversation between Dr. James Emery White and co-host Alexis Drye, they discuss the rapidly changing landscape of Christian wellness. The wellness industry is now a multi-trillion dollar global market, one that some within the Christian faith are aiming to capitalize on. They are taking culture's focus on prevention and lifestyle choices and washing all of it in faith - putting a Christian label or a Christian personality behind it to move a product. And “Christian” social media influencers are having a lot of success in gaining the trust of other Christians. Episode Links Alexis mentioned the article that prompted today's discussion written by Kelsey Kramer McGinnis in Christianity Today titled “‘No Guardrails' for Some Christian Wellness Influencers.” In it she notes how influencers are using Christian language and isolated Bible verses to sell everything from energy drinks to supplements, skin care to gym clothes. And the lack of guardrails is a huge concern, particularly when it's spreading distrust of the medical world. In response, Dr. White outlined what a social media influencer is. We had an earlier podcast episode on this topic that you can go back and listen to for a deeper discussion about influencers: CCP128: On Social Media Influencers. He also spent some time outlining the disproportionate influence that YouTube has had on our culture. Here's another past podcast episode that you can check out for more on this topic: CCP149: On YouTube. Finally, there are four additional articles that we'd encourage you to check out that were helpful sources for today's conversation. You can get to them by clicking the titles below: Coralie Kraft, “Why Some Teenage Girls Are Trading Medicine for MAHA,” The New York Times. Alexa Lee, “9 influencers shaping health information online, for better or worse,” STAT News. Ilana Amselem, “I Developed A Dark Obsession With 'Wellness.' Within Months, It Threatened To Consume My Life.” HuffPost. Ian Bogost, “People Are Thinking About Looksmaxxing All Wrong,” The Atlantic. For those of you who are new to Church & Culture, we'd love to invite you to subscribe (for free of course) to the twice-weekly Church & Culture blog and check out the Daily Headline News - a collection of headlines from around the globe each weekday. We'd also love to hear from you if there is a topic that you'd like to see discussed on the Church & Culture Podcast in an upcoming episode. You can find the form to submit your questions at the bottom of the podcast page HERE.

Dr. Justin Abbatemarco talks with Lizzy Lawrence about the FDA's shift toward single-trial drug approvals and its implications for neurology, rare diseases, and broader effects on drug approval standards and healthcare access.  Read the related article on STAT News.  Disclosures can be found at Neurology.org.   

Lev Facher, addiction reporter at STAT News, reports on how opioid overdose deaths began to fall in mid-2023 and have continued to decline. Photo: An emergency opioid overdose kit at Mount Royal University in Calgary, Alberta. (Credit: Chris Woodrich via Wikimedia Commons CC 4.0)

On this week's episode, Sam Fazeli, Josh Schimmer, Paul Matteis, and Graig Suvannavejh kick off with a discussion on the impact of current geopolitics on biotech investor sentiment, noting that biotech is fundamentally insulated from oil prices and emphasizing that the sector is becoming cash‑flow positive at a pace not previously seen. Shifting to regulatory news, the group discusses Vinay Prasad's departure from the FDA and highlights that upcoming rare disease readouts will serve as a test of the FDA's flexibility. They also cover the FDA's new Adverse Event Monitoring System, which consolidates multiple adverse event reporting databases into a single platform. Next, the co-hosts highlight John Crowley's opinion piece in STAT News on Biotech's 50th anniversary (marked by the founding of Genentech), emphasizing the importance of protecting U.S. biotech and pharmaceutical pricing to sustain innovation. On the deal front, the group discusses Servier's $2.5B cash acquisition of Day One Biopharmaceuticals' oncology asset, as well as the recurring rumor of an Abivax takeover. The episode closes with a review of recent clinical data and company updates from IDEAYA Biosciences, Roche, Benitec Biopharma, RenovoRx, Vertex, Xenon, and Dianthus, along with broader commentary on FDA decision‑making following the approval of leucovorin. *This episode aired on March 13, 2025.

These days, many internet influencers are promoting a wellness trend that sounds like something you might remember from high school bio: peptides. They’re being sold as ways to improve skin, reverse aging – basically, peptides have become THE answer to your choice of wellness issues. But most of what’s hawked on Instagram or TikTok is not approved by the FDA. . That could change: Health Secretary Robert F. Kennedy Jr. recently said on Joe Rogan’s podcast that he wants to relax restrictions on many peptides. In the meantime, people are accessing them through methods that some experts say are…. dangerous. Guests: Alex Hogan, a senior multimedia producer at STAT News and the host of STATus Report Related links: Inside the world of internet peptides | STAT News Peptides Are the New Wellness Cure-All | Intelligencer Why 'Anti-Aging' Peptide Shots Are Trending on Social Media | TIME Peptides take off as a DIY treatment but is that a good idea? : NPR Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

After Friday's news that Center for Biologics Evaluation & Research Chief Vinay Prasad will leave the FDA—again—at the end of April, stocks for several rare disease drug developers popped. UniQure, in particular, was up 51% in premarket trading on Monday. Prasad in a meeting last Thursday with select journalists called the biotech's Huntington's treatment AMT-130 a “failed” therapy, according to STAT News. Shares of Replimune and REGENXBIO—which have suffered rejections during the past year—also rose.One person who is not impressed with the plethora of rare disease drug rejections of late—H.C. Wainwright said in a note Tuesday that there have been at least five cell and gene therapies they believe could have been approved under prior FDA officials—is Wisconsin Senator Ron Johnson. Tuesday, Bloomberg News reported that Johnson has launched an investigation into these recent denials.Johnson called the FDA's request that uniQure conduct a sham surgery-controlled trial of AMT-130 “bureaucratic idiocy,” according to the publication. Meanwhile, uniQure and the FDA appear to be on different pages regarding the design of this prospective trial, with uniQure Chief Medical Officer Walid Abi-Saab referring to a 10-12 hour surgery during which [burr] holes would be drilled in patients' skulls and Prasad claiming on a media call last week that it would require only “one to three nicks in the scalp.”In other news, no episode of The Weekly would be complete without our weekly weight loss segment. Roche and Zealand Pharma's amylin analog fell short of Eli Lilly's rival candidate eloralintide; AbbVie reported what analysts called “competitive” results, with its amylin analog eliciting nearly 10% weight loss at 13 weeks in a Phase 1 trial; and Regeneron touted a much-needed Phase 3 win for Hansoh-partnered dual GLP-1/GIPR agonist olatorepatide in China. Beyond data, Novo Nordisk and Hims & Hers are together again, with Novo striking a deal to sell its injectable and oral GLP-1 medicines through the telehealth provider.Elsewhere on the business side of biopharma, experts are reporting a cut-throat atmosphere behind doors on the M&A front as the supply of companies available to buy dwindles.

Andrew Humberman BioSnap a weekly updated Biography.Andrew Huberman, the Stanford neuroscientist and host of the worlds top health podcast, dropped his latest Huberman Lab episode on February 23, just yesterday, diving deep into restoring youthfulness and vitality to the aging brain and body with guest Dr. Tony Wyss-Coray, a Stanford neurology professor pioneering blood biomarkers for organ health and disease risk, as detailed on the official Huberman Lab site. They unpacked young blood factors, rejuvenation via exercise and fasting, NAD levels, NMN supplements, and how sunlight plus deliberate deep breathing combat accelerated aging—timely stuff with massive long-term implications for anti-aging science that could redefine longevity protocols. No public appearances or business moves popped up in the last few days, but his podcast dominance holds steady, regularly topping charts on platforms like iHeart and Amazon Music. Social buzz simmers too: Food Ingredients First spotlighted Hubermans frequent plugs for hydrogen water as a potential 2026 breakout functional beverage, while STAT News on February 20 quoted him praising nicotine for sharpening the mind, fueling biohacker chatter among influencers like Joe Rogan. Fast Life Hacks updated its February 2026 rundown of his supplement stack—Tongkat Ali, Fadogia Agrestis, omega-3s, and sleep aids like magnesium threonate—based on his recent Rhonda Patrick chat, hinting at tweaks to his testosterone-boosting routine that keep fans dissecting his protocols. No verified headlines scream drama, but this episode rollout cements Hubermans grip on neuroscience gossip, with whispers of premium membership perks like AMA access drawing over a million email subs. All quiet on personal fronts—no unconfirmed rumors or scandals, just pure science fueling the wellness whirlwind.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

Health Affairs' Jeff Byers welcomes dietitian Jenny Lo from Wellness and Sports Dietetics to discuss the recently revised dietary guidelines for Americans. They discuss what's changed, the emphasis on protein, the ambiguity over ultraprocessed foods, and the best advice she gives to new clients looking to make dietary changes. Related Articles:Panel behind new dietary guidelines had financial ties to beef, dairy industries (Stat News)Experts Who Advised on Diet Guidelines Say RFK Jr.'s Version Is Full of Errors (MedPage Today)A Multilayered Public Policy Approach To Ultraprocessed Foods (Health Affairs Forefront)MAHA says its new food pyramid is affordable and healthy. We asked experts (Stat News)

Prescription drug costs are a key health policy issue for both parties. President Trump has recently implimented his approach, which he's billed as "Trump Rx"On Today's Show:Chelsea Cirruzzo Washington Correspondent for STAT News explains what the Trump administration's new prescription drug marketplace aims to do, and who might save money by using it.

Andrew Humberman BioSnap a weekly updated Biography.Andrew Huberman, the Stanford neuroscientist and Huberman Lab podcast kingpin, has been lighting up the wellness scene with fresh insights this week. In a GQ interview published Monday, he dished on his go-to routines for crushing it health-wise in 2026, from morning light exposure to smart hydration hacks that keep his edge sharp amid a packed schedule, according to AOL News. Just days earlier on January 23, he joined Chris Williamson on the Modern Wisdom podcast for a deep dive into burnout protocols, stressing bright mornings under 10,000 lux, dim nights no brighter than a full moon at one to five lux, and treating those first three to six hours as pure go-time with no caffeine slip-ups. Huberman even spilled on loosening his own protocols after a combative Trump interview listen, nodding to sleep evangelist Matthew Walkers decade-long influence via Joe Rogan.Social buzz reignited around his Bill Maher appearance, where Tyla reports Huberman dropped a quirky sleep hack for midnight wake-ups: eyes closed, side-to-side eye rolls behind lids paired with long exhales to fire up the vagal nerve and slow heart rate. Fans online swear by it, with one claiming it scored two extra hours of shut-eye after an early rise. No fresh public sightings or business moves popped, though his site hypes the pre-order for Protocols, his upcoming book on rewiring brains for peak performance, amid glowing subscriber testimonials calling it life-changing. STAT News nods to his enduring sway as a top influencer shaping health chatter, despite past LA residency drama. All verified, no whispers of scandals or unconfirmed flings—just Huberman stacking science into everyday wins. Word count: 378.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

Doctors are already using artificial intelligence to take notes while with patients—but are large language models ready to consult? Guest: Brittany Trang, health tech reporter for Stat News.Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.Podcast production by Evan Campbell, and Patrick Fort. Hosted on Acast. See acast.com/privacy for more information.

Doctors are already using artificial intelligence to take notes while with patients—but are large language models ready to consult? Guest: Brittany Trang, health tech reporter for Stat News.Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.Podcast production by Evan Campbell, and Patrick Fort. Hosted on Acast. See acast.com/privacy for more information.

Doctors are already using artificial intelligence to take notes while with patients—but are large language models ready to consult? Guest: Brittany Trang, health tech reporter for Stat News.Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.Podcast production by Evan Campbell, and Patrick Fort. Hosted on Acast. See acast.com/privacy for more information.

Doctors are already using artificial intelligence to take notes while with patients—but are large language models ready to consult? Guest: Brittany Trang, health tech reporter for Stat News.Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.Podcast production by Evan Campbell, and Patrick Fort. Hosted on Acast. See acast.com/privacy for more information.

John and Andrea discuss the STAT News article, “For some with bipolar disorder, manic episodes are magnified for all to see online.” John talks about social media insanity he partook in when he was manic. Wild times!

Dr. Marissa Russo trained to become a cancer biologist. She spent four years studying one of the deadliest brain tumors in adults and built her entire research career around a simple, urgent goal: open her own lab and improve the odds for patients with almost no shot at survival. In 2024 she applied for an F31 diversity grant through the NIH. The reviewers liked her work. Her resubmission was strong. Then the grant system started glitching. Dates vanished. Study sections disappeared. Emails went silent. When she finally reached a program officer, the message was clear: scrub the DEI language, withdraw, and resubmit. She rewrote the application in ten days. It failed. She had to start over. Again. This time with her identity erased.Marissa left the lab. She found new purpose as a science communicator, working at STAT News through the AAAS Mass Media Fellowship. Her story captures what happens when talent collides with institutional sabotage. Not every scientist gets to choose a Plan B. She made hers count.RELATED LINKSMarissa Russo at STAT NewsNIH F31 grant story in STATAAAS Mass Media FellowshipContact Marissa RussoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As patients, we often wonder what our role should be when it comes to getting better. Should we research options, get second opinions, and ask lots of questions? Or should we sit back, and let the health care professionals take charge? When does it make sense to push, and when is it best to do less?On this episode, we examine our role as patients, the choices we make, and charting our path toward better health. A reporter gets a wake-up call while looking into diabetes rates among Latinos in Oklahoma, we hear about one woman's choice to forgo cancer treatment — and how her family and doctors responded, and we explore a controversial proposed diagnosis for severe, long-term anorexia. SHOW NOTES: First Juliet Wayne's brother died from cancer — then her long-term partner broke up with her. That was followed by a deep depression; and then, the nightmares started. We talk with Wayne about how these nightmares affected her life, why doctors said she couldn't take a drug designed to stop them, and how a chance encounter finally led her to relief. Historian Joy Lisi Rankin talks about her mother's choice not to pursue treatment for breast cancer — and how Rankin's own experience years later with breast cancer treatment changed how she felt about her mother's choices. You can read Rankin's essay about her mother at Stat News. Anorexia has one of, if not the, highest mortality rates of any mental illness, with a relatively low recovery rate. Patients and their families suffer deeply from this illness, which can last for decades. In 2022, a paper proposed a new and controversial diagnosis: terminal anorexia. Reporter Elizabeth Zwerling tells the story of how this diagnosis came to be proposed, and the difficult conversations it kicked off in the world of eating disorder treatment.

For decades, Austinites have been known to live on the healthier side of life — Whole Foods was founded here, our greenbelts go on forever, and people cycle year-round. But in recent years, the health movement has changed somewhat, and is now represented in large part on popular podcasts, in a growing number of parent-requested vaccination exemptions, and increasingly, by politicians. On today's episode, host Nikki DaVaughn is joined by Isabella Cueto, a reporter with STAT News who recently reported that Austin is the heart of the Make America Healthy Again movement; and Travis McCormick, the founder of Make Texas Healthy Again, to dig into what being healthy in Austin means today, and how the MAHA movement is taking hold.   Want some more Austin news? Then make sure to sign up for our Hey Austin newsletter.  And don't forget– you can support this show and get great perks by becoming a City Cast Austin Neighbor at membership.citycast.fm  Follow us @citycastaustin You can also text us or leave a voicemail.  Interested in advertising with City Cast? Find more info HERE  Learn more about the sponsors of this December 18th episode: DUER - Get 15% off at shopduer.com/ccaustin Aura Frames - Get $35 off the Carver Mat frame with Promo Code CITYCAST The SAFE Alliance

This episode dives deep into the escalating chaos inside the FDA as leaders, scientists, and biotech insiders publicly revolt against the agency's current direction. Hosts Jonathan and Wendy break down the explosive STAT News investigations revealing mass resignations, internal fear, political interference, and allegations of mismanagement under V. Prasad's leadership. The episode unpacks the controversial rejection of a promising Huntington's disease gene therapy, accusations of shifting scientific standards, and the quiet but aggressive attempt by FDA officials — including Tracy Beth Høeg — to restrict access to COVID vaccines for young men. From vaccine policy upheavals to political pressure from the RFK Jr. administration, this conversation exposes the "soap opera" unraveling inside the nation's most important medical regulatory body — and what the turmoil could mean for patients, public trust, and the future of science in America. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

RFK Jr.'s autism claims aren't about helping anyone—they're about deciding who gets to exist in America.

You requested; we delivered. Lots of Science Fictions listeners have asked us to take a look into Donald Trump and RFK, Jr.'s recent claims about Tylenol (that is, paracetamol or acetaminophen—all the same thing). Does it cause autism?It turns out there's more to this than you might've thought—regardless of all the recent hype, a lot of very reputable scientists take the idea seriously. But should they? In this emergency podcast, we go through all the relevant studies.The Science Fictions podcast is brought to you by Works in Progress magazine. In the ad this week we mentioned “The Death Rays that Guard Life”, an article from Issue 20 of the magazine about far-UVC light and how—with a lot more research—it might be the next big thing for reducing the spread of germs in hospitals and classrooms. Find that and many other articles and podcasts at worksinprogress.co.Show notes* The FDA's September 2025 announcement on Tylenol and autism* The UK's Department of Health and Social Care announcement the same day* “The phrase ‘no evidence' is a read flag for bad science communication”, by Scott Alexander* 2003 theoretical paper with speculation about paracetamol and neurodevelopmental disorders* 2013 sibling control study in the International Journal of Epidemiology* “Ecological” study in Environmental Health from 2013 about circumcision rates, paracetamol, and autism* 2015 Danish seven-year follow-up study* 2019 cord blood study in JAMA Psychiatry* 2021 “consensus statement” on paracetamol and neurodevelopment* 2025 Japanese sibling-control study* 2024 very large Swedish sibling-control study* Study that sparked the current debate: the “Navigation Guide” review from Environmental Health* Description of what “Navigation Guide” is* STAT News on the evidence for a paracetamol-autism link; and on the controversy about the Dean of the Harvard School of Public Health* White House statement defending the existence of the link* BMJ article summing up the controversyCreditsThe Science Fictions podcast is produced by Julian Mayers at Yada Yada Productions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit sciencefictionspod.substack.com/subscribe

For decades, pregnant women have been excluded from most clinical drug trials. The policy was meant to protect mothers and babies, but it has left major gaps in medical knowledge. Now, renewed debate over the safety of common medicines like Tylenol has brought those gaps into sharp focus. In this episode, STAT News reporter Lizzy Lawrence joins host J. Carlisle Larsen to discuss how history, politics, and caution shaped the science of pregnancy, and what it will take to ensure women are fully included in research that affects their health. You can read her piece here. Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Zenas has made a $2 billion bet on autoimmune diseases with Chinese firm InnoCare, focusing on the development of orelabrutinib for multiple sclerosis. Former FDA director Peter Marks has joined Eli Lilly, marking the company's continued push in China. Sanofi's advancements in radiopharma, Boehringer Ingelheim's breakthrough in idiopathic pulmonary fibrosis, and Takeda's exit from cell therapy are also top stories. Cytiva filtration is highlighted as a solution for maintaining product integrity in biopharma.Biospace profiles the five most powerful women leading smaller biopharmaceutical companies, as the industry sees a shift with the departure of GSK CEO Emma Walmsley. A survey by CRB reveals that most life sciences companies are not planning new investments after tariffs, with big pharma taking the lead in manufacturing initiatives. Drug pricing criticism often overlooks the dynamic nature of drug pricing over time. Takeda's journey in building a cell therapy portfolio, only to ultimately walk away, is explored. Pfizer wins the bid for Metsera, Amgen offers Repatha at a discounted rate, and Roche acquires Akero for $3.5 billion. Biospace also honors 40 under 40 winners making an impact in the industry.Peter Marks, former director of the FDA's Center for Biologics Evaluation and Research, has taken on a new role as Senior Vice President for molecule discovery and the head of infectious diseases at Eli Lilly. Marks' controversial exit from the FDA led to his hiring by Lilly, following in the footsteps of another former FDA official, Rachael Anatol. Marks confirmed his new role to Stat News and began his first day at Lilly Research Laboratories on Monday.Support the show

Federal cuts to the the NIH and other key research organizations have left both researchers and patients paying the price. Erika Moseson, MD, of the Air Health Our Heath podcast, talks with Mary Rice, MD, MPH, of Harvard T.H. Chan School of Public Health, about how these cuts have not only hurt her research on helping patients with respiratory illnesses, but the larger impact they have on science now and for future generations. Read the article in STAT News about Dr. Rice's study: https://www.statnews.com/2025/08/08/trump-cuts-include-cost-saving-research/ 

Chelsea Cirruzzo, Washington correspondent for STAT News, talks about the White House press conference on autism, acetaminophen, and immunizations, plus the results of last week's meeting of the federal advisory committee on vaccines, and the confusion over federal, state and local public health rules.

After President Trump and his public health chief raised concerns about the use of acetaminophen while pregnant, we look at what the science has to say.On Today's Show:Chelsea Cirruzzo, Washington correspondent for STAT News, talks about the results of last week's meeting of the federal advisory committee on vaccines and other public health news. 

Content note: This episode describes my guest's experience with psychosis, delusions, and suicidality / suicide attempts. Sally Littlefield is a national speaker and mental health advocate dedicated to changing how the world understands schizophrenia. After experiencing a 10-month long psychotic episode that led to a diagnosis of schizoaffective disorder, she returned to work in communications and fundraising roles at three mental health nonprofits. This professional experience deepened her insight into trauma, stigma, and systemic barriers faced by people with serious mental illnesses.  Sally's writing has appeared in Slate, STAT News, and Psychology Today, and she has been featured in national media such as the Associated Press and the television network A+E. Now a full-time advocate, she offers talks and trainings focused on stigma reduction, recovery, and mental health crisis de-escalation. Her mission is to promote empathy, dignity, and understanding for people with schizophrenia. During this episode, you will hear Sally talk about: What schizoaffective disorder is, and how it differs from schizophrenia and bipolar disorder Her experience of hospitalizations, misdiagnosis, and the prolonged psychotic episode where she believed her life was a hyperreality psychological experiment How society dehumanizes and dismisses people with schizophrenia spectrum illnesses Finally accepting that she has schizoaffective disorder and deciding to become a mental health advocate Learn more about Sally and her work at SallyLittlefield.com, on LinkedIn and on Instagram @schizophrenicsally. Watch the video of this interview on YouTube. Read the episode transcript. Follow the Beyond 6 Seconds podcast in your favorite podcast player. Subscribe to the FREE Beyond 6 Seconds newsletter for early access to new episodes. Support or sponsor this podcast at BuyMeACoffee.com/Beyond6Seconds! *Disclaimer: The views, guidance, opinions, and thoughts expressed in Beyond 6 Seconds episodes are solely mine and/or those of my guests, and do not necessarily represent those of my employer or other organizations. These episodes are for informational purposes only and do not substitute for professional medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment.*

Episode 70 of Body Justice is truly a gift of wisdom from my dear friend and colleague, Alishia McCullough. In this episode we talk about some of the core concepts from her book, Reclaiming the Black Body. In this episode we explore:How EDs show up for Black girls/womenShifting terminology from Eating Disorders to Eating Imbalances Adultification Bias and the Hypersexualization of Black women and femmesThe ties between colonization, the trans Atlantic slave trade and eating imbalancesThe trafficking of Saartjie Baartman and the conflation of fatness and blacknessIntergenerational body traumaMaternal disdain and rejection of daughters as a survival tactic from enslavement What healing looks like through this lens, what it means to truly Reclaim the Black BodyAbout Alishia: Alishia McCullough (LCMHC) is a millennial Licensed Clinical Mental Health Therapist and owner of Black and Embodied Consulting PLLC. She specializes in somatic therapy, trauma healing, and eating disorder treatment with a focus on cultivating embodiment and fostering anti-oppression. In 2020, Alishia co-founded the Amplify Melanated Voices Movement, a global movement to elevate the voices of Black, Indigenous, and other People of Color online and in-person. Alishia currently runs the self-paced online course Reimagining Eating Disorders 101. She  was awarded the 2023 Alumni Award from the Department of Psychology for the noteworthy contributions she has made to the field. An accomplished writer, Alishia is the author of a collection of poems called Blossoming, and  Reclaiming the Black Body now available in bookstores nationwide. In her work, Alishia centers the intersectional narratives of Black, Brown, Indigenous, Asian, dual-heritage, and individuals indigenous to the Global South, andor those who have been racialized as 'ethnic minorities' experiencing mental and emotional distress. She also specializes in working with those living with eating disorders, upholding the values of body justice and fat liberation. She was one of the Mental Health Influencers in Meta's 2022 Well-Being Collective. Alishia's work has been featured in Bustle, WordInBlack, STAT News, BlackGirlNerds, Essence, Reckon, Wondermind, Pen America and Forbes.*As always this podcast is for educational and informational purposes only. It does not constitute individual medical or therapeutic advice. Please reach out if you are interested in becoming a therapy or coaching client: www.eatingdisorderocdtherapy.com or visit my instagram for more info: @bodyjustice.therapist

In this episode of We Want Them Infected, Dr. Jonathan Howard and Wendy Orent unpack the shocking CDC shooting in Atlanta, which many are calling “public health's January 6th.” They trace how years of anti-science rhetoric from figures like RFK Jr., Jay Bhattacharya, and Vinay Prasad have fueled violent consequences. They also welcome their first guest, Dr. Philipp Markolin PhD, author of Lab Leak Fever. Dr. Markolin shares his global reporting on COVID's origins, dismantles the so-called “lab leak” hypothesis, and explains how disinformation has been weaponized for politics and power. From epidemiological evidence at the Wuhan market to the ghost DNA of raccoon dogs, he outlines why science overwhelmingly supports a zoonotic origin. This episode tackles misinformation, political corruption, and the dangerous future of science under attack—while honoring the tragic loss of a young officer in the CDC shooting. Resources Mentioned Dr. Phillipp Markolin: Lab Leak Fever → https://www.lab-leak-fever.com/about STAT News article: “The CDC Shooting Was Public Health's January 6th” by Colin Carlson & Sean Kennedy STAT News article: “Kennedy's Case Against mRNA Vaccines Collapses Under His Own Evidence” by Dr. Jake Scott LA Times: Coverage of COVID resurgence in the Southwest, fall 2025 MedPage Today: “The Executive Order That Could Cripple Science” by Adam Brown Science-Based Medicine: Analysis of Jay Bhattacharya and NIH policy shifts Audrey Tang (Taiwan's Cyber Minister) – discussed as a model for democratic info ecosystems Guest Bio – Dr. Philipp Markolin Dr. Philipp Markolin, PhD is a Switzerland-based science writer and author of Lab Leak Fever, a definitive investigation into the origins of COVID-19. Trained in molecular biology and machine learning, Dr. Markolin spent more than a decade in academia before transitioning to science communication during the pandemic. He has written extensively on the intersection of science, conspiracy theories, and society, and has interviewed leading virologists, field researchers, and policymakers around the world. His reporting has taken him into wildlife markets and labs, where he traced the evidence that overwhelmingly supports a zoonotic origin for COVID-19. Dr. Markolin also co-produced a documentary film exploring the pandemic's origins and the scientists at the center of the controversy. He writes the blog Protagonist Science and speaks globally on the dangers of misinformation and the urgent need to protect scientific integrity. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.  The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information. The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content. The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content. Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer. Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

For Helen Branswell, the celebrated Stat News reporter, the SARS outbreak of 2003, while she was based in Toronto, was a thunderclap moment. Jump forward 22 years: Secretary Kennedy on May 28, posted a one-minute video on X announcing he is not recommending Covid vaccines for healthy children and pregnant women -- an “unprecedented” unilateral decision without any normal process. “It came out of the mind of the individuals who wrote it.” What does this bold step signal?  The public is voting with its feet in the low uptake of Covid vaccines by the older and more vulnerable population. Yet it is not clear why the government has to take active measures to make vaccines less available to healthy individuals. CDC should play a lead role in deliberations but is cut out. The CDC director position is vacant, and no acting director is in place.  Will vaccine producers need to run new field trials for updated boosters? “They (the Trump administration) have been quite unclear in what they are asking for.”127 days into the second Trump administration, how to characterize things?  “I would characterize it as exhausting.”  “The change has been massive, and it is not over.”  What gives you hope? “That is a very hard question.” 

Episode 191: Diagnosis of ADHDFuture Dr. Granat explains how to diagnose Attention Deficit Hyperactivity Disorder. She explained the influence of social media in increasing awareness of ADHD. Dr. Arreaza added input about the validated tools for ADHD diagnosis and highlighted the importance of expert evaluation for the diagnosis of this disorder.  Written by Yen Stephanie Granat, MSIV. Ross University School of Medicine. Comments and editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Steph: I love podcasts—many of us do—and if you, like me, spend any amount of your leisure time listening to podcasts, perusing the news, or scrolling social media; you've likely noticed an alarming trend in the number of discussions we seem to be having about ADHD. It has grown into a very hot topic over the past couple of years, and for some of us, it seems to have even begun sneaking into our “recommended videos” and across our news feeds! Naturally, for the average person this can spur questions like:“Do I have ADHD? Do we all have it? How can I be certain either way, and what do I do if I find myself relating to most of the symptoms that I'm seeing discussed?”Granted that there is a whirlpool of information circulating around this hot topic, I was hoping to spend a bit of time clearly outlining the disorder for anyone finding themselves curious. I believe that can best be achieved through outlining a clear, concise, and easy-to-understand definition of what ADHD is; outlining what it is not; and helping people sift through the fact and the fiction. As with many important things we see discussed on the internet, we're seeing is that there is much more fiction than fact. Arreaza: I'm so glad you chose this topic! I think it is challenging to find reliable information about complex topics like ADHD. Tik Tok, Instagram and Facebook are great social media platforms, but we have to admit that fake news have spread like a fire in recent years. So, if you, listener, are looking for reliable information about ADHD, you are in the right place. With ADHD, there aren't any obvious indicators, or rapid tests someone can take at home to give themselves a reliable “yes” or “no” test result. People's concerns with ADHD are valid, and important to address, so we will discuss the steps to identify some of signs and symptoms they are seeing on TikTok or their favorite podcaster. Steph: Healthcare anxiety is a vital factor to consider when it comes to large cultural conversations around our minds and bodies; so, I hope to sweep away some of the misconceptions and misinformation floating around about ADHD. In doing so, I want to help alleviate any stress or confusion for anyone finding themselves wondering if ADHD is impacting their lives! We might even be able to more accurately navigate these kinds of “viral topics” (for lack of a better term) next time we see them popping up on our news feeds.Arreaza: The first thing I want to say about ADHD is “the crumpled paper sign.”Steph: What is that?Arreaza: It is an undescribed sign of ADHD, I have noticed it, and it is anecdotal, not evidence based. When I walk into a room to see a pediatric patient, I have noticed that when the paper that covers the examination table is crumpled, most of the times it is because the pediatric patient is very active. Then I proceed to ask questions about ADHD and I have been right many times about the diagnosis. So, just an anecdote, remember the crumpled paper sign.  Steph: When you have patients coming to you asking for stimulants because they think they have ADHD, hopefully, after today, you can be better prepared to help those patients. So, for the average person—anyone wanting to be sure if this diagnosis applies to them—how can we really know?”Arreaza: So, let's talk about diagnosis.Steph: Yes, the clearest information we have is the DSM-5, which defines these disorders, as well as outlines the specific criteria (or “checkpoints”) one needs to meet to be able to have a formal diagnosis. However, this manual is best utilized by a trained professional—in this case, a physician—who can properly assess your signs and symptoms and give you a clear answer. Steph: ADHD stands for Attention Deficit Hyperactivity Disorder. It is among the most common neurodevelopmental disorders of childhood. That is not to say it does not affect adult—it does—and because it can be easy to miss, it's very possible for someone to have ADHD without knowing. Arreaza: I recently learned that ADD is an outdated term. Some people with ADHD do not have hyperactivity but the term still applies to them. Steph: Yes, there are multiple types that I will explain in just a bit. But overall the disorder is most simply characterized by a significant degree of difficulty in paying attention, controlling impulsive behaviors, or in being overly active in a way that the individual finds very difficult to control. (CDC)Arreaza: How common is ADHD?Steph: The most recently published data from The CDC estimates that 7 million (11.4%) of U.S. children between the ages of 3 and 17 have been diagnosed with ADHD. For adults, it is estimated that there are 15.5 million (6%) individuals in the U.S. who currently have ADHD. Arreaza: I suspected it would be more than that. [Anecdote about Boy Scout camp]. Steph: I totally agree. With short videos on TikTok, or paying high subscription fees to skip ads, it feels like as a society we all have a shorter attention span. Arreaza: Even churches are adapting to the new generation of believers: Shorter sermons and shorter lessons.Steph: When it comes to better understanding these numbers, it's also important to know that there are three distinct presentations of ADHD recognized by The CDC and The World Health Organization. Arreaza: The DSM-5 TR no longer uses the word “subtypes” for ADHD. Instead, it uses the word "presentation" to describe the different ways that ADHD may manifest in a person. That reminded me to update my old DSM-5 manual and I ordered it while reading today about ADHD. This means people with ADHD are no longer diagnosed as having a “subtype”. Instead, they are diagnosed with ADHD and a certain “presentation” of symptoms.Steph: These presentations are:Inattentive TypePeople often have difficulty planning or completing tasksThey find themselves easily distracted (especially when it comes to longer, focus-oriented tasks)They can often forget details and specifics, even with things that are part of their daily routineThis used to be referred to as “ADD” (you'll notice the absence of an “H”, segue).Hyperactive-Impulsive TypePeople often have a sense of intense “restlessness”, noticeable even in calm environments.They tend to be noticeably more talkative, and might often be seen interrupting others, or finishing their sentences.They find significant difficulty in being still for extended periods. Because of this, they are often unable to sit through a movie or class time, without fidgeting or getting up and moving around.With this category of ADHD, we often see an impulsiveness that unwittingly leads to risky behavior. Because of this, accidents and bodily injury are more common in individuals with this type of ADHD.Combined TypeThese are individuals who exhibit symptoms from both “Inattentive” and “Hyperactive-Impulsive” ADHD equally.Some listeners might have noticed that the categories are quite different, meaning that ADHD presents in different ways depending on the person! Two people who have ADHD can be in the same room and have vastly different presentations, whilst still having many of the same types of challenges. You also might have noticed what makes the discussion so interesting to the general public, which is also the thing that makes speaking to a professional to get formally tested so important:The diagnostic criteria rely heavily on patterns of behavior, or external variables; rather than on how a person might feel, or certain measurements taken from lab tests.Arreaza: Diagnosing ADHD requires evaluation by a professional who is properly trained for this. Fortunately, we have tools to assist with the diagnosis. The attention deficit must be noted in more than one major setting (e.g., social, academic, or occupational), that's why the information should be gathered from multiple sources, including parents, teachers, and other caregivers, using validated tools, such as:The Neuropsychiatric EEG-Based ADHD Assessment Aid (NEBA), recommended by the American Academy of NeurologyThe Vanderbilt ADHD Diagnostic Parent Rating Scale (VADPRS) and the Vanderbilt ADHD Diagnostic Teacher Rating Scale (VADTRS), recommended by the Society for Developmental and Behavioral Pediatrics.For adults: The validated rating scales include the Adult ADHD Self-Report Scale (ASRS) and the Conners Adult ADHD Rating Scales (CAARS).Steph: This is important because nearly everyone alive has experienced several, if not most, of these behavioral patterns at least once. Whether or not an individual has ADHD, I'm certain we could all think of moments we've had great difficulty focusing or sitting still. Perhaps some of us are incredibly forgetful, or act more impulsively than the average person might find typical. Getting a professional diagnosis is important because it is in skillfully assessing “the bigger picture” of a person's life, or their patterns of behavior, that a skilled physician, who understands the nuances and complexities in these disorders, can properly tell each of us whether we have ADHD, or not.Essentially, most of us could stand to use a bit more focus these days, but far fewer of us would meaningfully benefit from the kinds of treatments and therapies needed by individuals with ADHD to live healthier, more happy and regulated lives.Arreaza: I had a mother who came to discuss the results of the Vanderbilt Questionnaire. I think she left a little disappointed when she heard that, based on the responses from her and the teacher, her son did not have ADHD. Some kids may have behaviors such as being distracted during a meeting, forgetting about homework or having a lot of energy, but that does NOT mean necessarily that they have ADHD, right?Steph: Absolutely! The important thing to remember here is that these patterns of behavior outlined in the DSM-5 are merely an external gauge for a neurological reality. What the science is showing us is that the brains of people with ADHD are wired differently than that of the more “neurotypical” brain. Much like a check engine light would serve as a signal to a driver that something under the hood needs attention; these patterns of behavior, when they begin impeding our day to day lives, might tell us that it's time to see a professional (whether it be an auto mechanic or a trained physician). I think we all know someone who drives with their check engine light and not a care in the world. Arreaza: How serious/urgent is ADHD? Why should we care to make the diagnosis?Steph: Although we've yet to see anyone incur harm solely from having ADHD, it does lead to quite a range of more serious issues, some of which might prove more urgent. In the cases of ADHD, specifically, what we know is that there is a notable degree of dysregulation in some key neurotransmitters, like dopamine and norepinephrine. More plainly, what we are seeing in the brains of people with ADHD is a disruption, or alteration, of some of the brain's key chemicals.These neurotransmitters are largely responsible for much-needed processes like Motivation, Satisfaction, Focus, Impulse control, even things like energy and feelings of happiness. Many of these things serve as “fuel” for our day-to-day lives; things we'd call our “executive function”.  These are also what prove dysfunctional in those struggling with ADHD. It is in this sense that we might be able to bridge a meaningful gap between ADHD as being seen through patterns of behaviorthat signal a real, neurological reality.Steph: We often hear of the brain referenced as a kind of supercomputer. A more accurate assessment might be that the brain is more of a network of interconnected computers that run different processes and require continual communication with one another for our brain to function properly and seamlessly. What we're seeing in members of the population with this diagnosis, is a significant disruption in these lines of communication. Although this is a very broad oversimplification, for the purposes of our metaphor is to think of it like our brain chemicals getting caught in a traffic jam, or parts of our brain attempting to communicate to one another with poor cell signal. Arreaza: Making the diagnosis is critical to start treatment because having that level of dysfunction sounds like having a very difficult life.Steph: Yeah! I think that's why this conversation matters so much. There's a sense of urgency there, because much of life is, in fact, boring. Things like paying bills, exercising and eating well, work and school—these are all things that are vital to health and wellbeing in day-to-day life; and for the more neurotypical brain, these things might prove occasionally challenging. Yet, they are still doable. For those with ADHD however, this goes far beyond mere boredom or “laziness” (which proves to be a trigger term for many—more on that in just a bit).For folks listening, I wanted to offer some statistics that show why this is such a big concern for the public, whether one has a formal ADHD diagnosis or not. The facts are figures are:Children with ADHD are more than five times as likely as the child without ADHD to have major depression.A significant increase in the prevalence of anxiety is seen in ADHD patients, ranging from 15% to 35%, when accounting for overlap in symptoms.There are significant correlations in youth diagnosed with ADHD, and those diagnosed with what are known as “externalizing disorders”. These are things like Conduct Disorder, Disruptive Mood Dysregulation Disorder, and Oppositional Defiant Disorder.We are seeing a much higher rate of academic problems in kids who have ADHD, like reading disorder, impaired verbal skills, and visual motor integration.We're finding that many, if not most, of these connections are being made after diagnosis. In the case of the “internalized disorders”, like depression and anxiety, we're often seeing years between ADHD diagnoses and the diagnoses of major depressive disorder or anxiety disorders. Given this framework, much of the data is theorized to point towards what we call “negative environmental circumstances”, otherwise known as “ADHD-related demoralization”.For children, this often looks like struggling with sitting still during class, failing to get homework done (because they forgot, or couldn't focus on the tasks at hand), and struggling to focus their attention on what their teacher is saying during lecture. These things often lead to bad grades, discipline or forced time sitting still in detention. This can be seen in more problems at home, with children being disciplined often for behavior that they struggle immensely to control.For adults, this can mean forgetting to pay your bills, missing work meetings, having trouble making appointments, or having difficulty with day-to-day tasks, really anything that requires sustained attention. We often see adults with ADHD who are chasing normalcy with caffeine addictions or even struggling with substance use. Arreaza: Substance use disorder actually can be a way for some people living with ADHD to self-treat their symptoms. Steph: These differences between the individual's experience and the world around them can lead to really powerful feelings of failure or inadequacy. They can affect your social life, your sense of community, and even further limit your capacity to seek help.Literacy in these things is so important—not just for the individual who feels that they may have ADHD, but also for those who are likely to encounter people with ADHD in their own lives. Understanding why some of these patterns pop up, even those who might not have a formal diagnosis, can go a long way to properly approaching these behaviors with success and with empathy.Arreaza: Learning about ADHD is fundamental for primary care doctors. We talked about the high prevalence and the influence of the media in increasing awareness and sometimes increasing public panic. So, we have to be prepared to diagnose or undiagnosed ADHD. Steph: Whether we're the physicians in the room, or the patient in the chair, I think it's important to have a clear understanding of what ADHD is and how it can affect lives. Thanks for listening, I hope we were able to teach you a little more about ADHD. ______________Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _______________References:NICHQ-Vanderbilt-Assessment-Scales PDF: https://nichq.org/wp-content/uploads/2024/09/NICHQ-Vanderbilt-Assessment-Scales.pdfADHD: The facts. ADDA - Attention Deficit Disorder Association. (2023, January 11). https://add.org/adhd-facts/American Psychiatric Association, DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5™ (5th ed.). American Psychiatric Publishing, Inc. https://doi.org/10.1176/appi.books.9780890425596.Gnanavel S, Sharma P, Kaushal P, Hussain S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019 Sep 6;7(17):2420-2426. doi: 10.12998/wjcc.v7.i17.2420. PMID: 31559278; PMCID: PMC6745333.Staley BS, Robinson LR, Claussen AH, et al. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October – November 2023. CDC.Gov, MMWR Morb Mortal Wkly Rep 2024;73:890-895.Danielson ML, Claussen AH, Arifkhanova A, Gonzalez MG, Surman C. Who Provides Outpatient Clinical Care for Adults With ADHD? Analysis of Healthcare Claims by Types of Providers Among Private Insurance and Medicaid Enrollees, 2021. J Atten Disord. 2024 Jun;28(8):1225-1235. doi: 10.1177/10870547241238899. Epub 2024 Mar 18. PMID: 38500256; PMCID: PMC11108736. https://pubmed.ncbi.nlm.nih.gov/38500256/Mattingly G, Childress A. Clinical implications of attention-deficit/hyperactivity disorder in adults: what new data on diagnostic trends, treatment barriers, and telehealth utilization tell us. J Clin Psychiatry. 2024;85(4):24com15592. https://www.psychiatrist.com/jcp/implications-adult-adhd-diagnostic-trends-treatment-barriers-telehealth/Didier J. My four kids and I all have ADHD. We need telehealth options. STAT News. Published October 10, 2024. Accessed October 10, 2024. https://www.statnews.com/2024/10/10/adhd-medication-shortage-telehealth-dea-congress/.Hong J, Mattingly GW, Carbray JA, Cooper TV, Findling RL, Gignac M, Glaser PE, Lopez FA, Maletic V, McIntyre RS, Robb AS, Singh MK, Stein MA, Stahl SM. Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder. CNS Spectr. 2024 May 20:1-12. doi: 10.1017/S1092852924000208. Epub ahead of print. PMID: 38764385. https://pubmed.ncbi.nlm.nih.gov/38764385/Gabor Maté: The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture. (2022). Youtube. Retrieved April 27, 2025, from https://www.youtube.com/watch?v=ttu21ViNiC0. Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

Sponsored by: Set for LifeSet For Life Insurance helps doctors safeguard their future with True Own Occupational Disability Insurance. A single injury or illness can change everything, but the best physicians plan ahead. Protect your income and secure your future before life makes the choice for you. Your career deserves protection—act now at https://www.doctorpodcastnetwork.co/setforlife_______________ In an era where misinformation can masquerade as science, how do you discern credible research? Host Dr. Bradley Block welcomes Dr. Katie Suleta, to unpack the importance of scrutinizing study authors and journals for conflicts of interest. Drawing from her recent experience with the Journal of Personalized Medicine, where a case study on supplements for autism treatment failed to disclose a lead author's affiliation with a supplement company, Dr. Suleta shares her journey to push for its retraction. This episode equips physicians with tools to inoculate themselves against junk science, emphasizing intellectual humility and lateral reading to protect patient care and public trust.Three Actionable Takeaways:Check Author Affiliations – Before reading a study, investigate authors' affiliations and potential conflicts of interest using readily available information to assess bias.Evaluate Journal Credibility – Be wary of journals with overly long or suspicious titles, and research their reputation to avoid predatory publications.Practice Lateral Reading – Cross-check studies or news articles with other sources to verify credibility and understand broader reactions, enhancing your information hygiene.About the Show:PGD  Physician's Guide to Doctoring covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Katie Suleta is a trained epidemiologist with expertise in infectious diseases and health informatics, serving as the regional director of research and graduate medical education. She mentors residents daily and works as a science writer, contributing to outlets like the American Council on Science and Health, The Conversation, Skeptical Inquirer, and STAT News. Known for her advocacy against misinformation, Dr. Saleta recently exposed a case study in the Journal of Personalized Medicine where a lead author's undisclosed supplement company affiliation led her to push for its retraction, highlighting the need for transparency in scientific publishing.LinkedIn: http://linkedin.com/in/katherine-sota-ortecho-447a4899Instagram: https://www.instagram.com/katysota?igsh=Njd0NG4weW90OWJiAbout the Host Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts The Physician's Guide to Doctoring podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance.

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers welcomes Bob Herman of STAT News to the program to discuss the state of deals in the health care space, how vertical integration and consolidation have played a role in mergers & acquisitions as it relates to hospitals, and what might fly under the radar from even the most savvy of health policy wonks.Health Affairs Insiders can join us April 23 for an exclusive virtual event exploring site-neutral payments with health economist and health services researcher Brady Post of Northeastern University and Health Affairs' Meg Winchester.Also, we are hosting another Insider exclusive event on May 29 focusing on the FDA's first 100 days under the second Trump administration featuring moderator Rachel Sachs alongside panelists Richard Hughes IV and Arti Rai. Related Links:Sign up for STAT+Sign up for STAT newsletters including Bob Herman's Health Care Inc. Subscribe to UnitedHealthcare's Community & State newsletter.

El Salvador President Nayib Bukele said he will not help return Kilmar Abrego Garcia to the U.S. after Garcia was mistakenly deported to El Salvador. NBC News has more. And Rolling Stone reports on private White House considerations about sending U.S. citizens there as well. Joseph Walker from the Wall Street Journal joins to talk about a possible way that Republicans could cut Medicaid funding. Anil Oza, Sharon Begley fellow at Stat News, discusses the rise in U.S. maternal mortality rates. Plus, Harvey Weinstein goes back on trial, an internal government memo refutes the narrative behind the detainment of a Tufts University student, UConn star Paige Bueckers was selected first in the WNBA draft, and why the IRS is extending the tax-filing deadline for certain states. Today’s episode was hosted by Shumita Basu.

The Trump Administration began terminating thousands of staff and purging some of the top leaders at the Department of Health and Human Services. It included several key agencies, including the Food and Drug Administration, the National Institutes of Health and the Centers for Disease Control and Prevention. Geoff Bennett discussed more with Matthew Herper of STAT News. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Send us a textIn this packed episode of Neo News, Eli, Ben, and Daphna dive into the headlines impacting neonatology and public health. The trio starts with the controversial confirmation of Robert F. Kennedy Jr. as head of HHS, analyzing his actions around the CDC, NIH, vaccine policy, and the implications of promoting “informed consent” messaging in place of public health advocacy. Drawing from reporting by The New York Times, STAT News, and Science Magazine, the team unpacks how these shifts could affect vaccine uptake in the NICU.Next, they examine the threat to birthright citizenship in the U.S., based on analysis from The New York Times, and how immigration policy may directly impact NICU families' access to care and trust in healthcare systems.They also discuss a Wall Street Journal article detailing the erosion of trust in physicians post-pandemic and the fallout from a recent JAMA Pediatrics study on therapeutic hypothermia in late preterms, which raised questions about research transparency.Other highlights include studies from Scientific Reports, JAMA Network Open, and The New York Times on air pollution, paternity leave, language-concordant care, and breastfeeding. The show ends with a call to action from Dr. Shadel Shah's op-ed advocating for the continuation of the PREEMIE Act. As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

On today’s show: It’s been a busy week for Tesla and Elon Musk. The Wall Street Journal’s Becky Peterson explains how his relationship with Trump is impacting his businesses. Sarah Owermohle from Stat News dives deep into the past of CDC nominee Dave Weldon and his prior anti-vaccine stances. The Washington Post’s Mary Beth Sheridan examines Trump's unique relationship with Mexican President Claudia Sheinbaum. Plus, a judge says Palestinian activist Mahmoud Khalil will remain in a Louisiana immigration jail for now, why a congressional hearing came to an abrupt end over gender identity, and the surprising outcome of Greenland’s election. Today’s episode was hosted by Shumita Basu.

After the fatal shooting of UnitedHealthcare's chief executive caused public outcry against the health care industry, Rachel Cohrs Zhang, chief Washington correspondent for STAT News, examines what Congress is trying to do to fix a system that many Americans think is broken.

The US saw a significant drop in the number of drug overdose deaths. The Trump administration has a shot at keeping the trend going. STAT News's addiction reporter, Lev Facher, explains. This episode was produced by Haleema Shah, edited by Amina Al-Sadi, fact-checked by Laura Bullard, engineered by Patrick Boyd, and hosted by Noel King. An addiction recovery billboard in Minneapolis. Photo by Michael Siluk/UCG/Universal Images Group via Getty Images. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Gothamist's Brittany Kriegstein explains who police just arrested. STAT News's Bob Herman explains the anger resonating against UnitedHealthcare. This episode was produced by Miles Bryan and Hady Mawajdeh, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Patrick Boyd and Rob Byers, and hosted by Sean Rameswaram. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Luigi Mangione, the suspect in the shooting of UnitedHealthcare CEO Brian Thompson, in an Altoona Police Department handout photo. Photo by Altoona Police Department via Getty Images. Learn more about your ad choices. Visit podcastchoices.com/adchoices